Resumen
The development of new antimalarial compounds remains a pivotal part of the strategy for malaria elimination. Recent large-scale phenotypic screens have provided a wealth of potential starting points for hit-to-lead campaigns. One such public set is explored, employing an open source research mechanism in which all data and ideas were shared in real time, anyone was able to participate, and patents were not sought. One chemical subseries was found to exhibit oral activity but contained a labile ester that could not be replaced without loss of activity, and the original hit exhibited remarkable sensitivity to minor structural change. A second subseries displayed high potency, including activity within gametocyte and liver stage assays, but at the cost of low solubility. As an open source research project, unexplored avenues are clearly identified and may be explored further by the community; new findings may be cumulatively added to the present work.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 687-701 |
| Número de páginas | 15 |
| Publicación | ACS Central Science |
| Volumen | 2 |
| N.º | 10 |
| DOI | |
| Estado | Published - oct 26 2016 |
Nota bibliográfica
Publisher Copyright:© 2016 American Chemical Society.
Financiación
Medicines for Malaria Venture (MMV), the Australian Research Council (LP120100552, LP120200557), the Australian National Health and Medical Research Council (Project Grant 1042272). G.P. and J.P.O. were supported by EMBL Member States and MMV. The characterization by NMR spectroscopy of compounds from Lawrence University was made possible by the National Science Foundation (CHE- 0923473). C.S. was supported by Wellcome Trust Biomedical Resources Grant 099156/Z/12/Z.
| Financiadores | Número del financiador |
|---|---|
| European Molecular Biology Laboratory | |
| Australian Research Council | LP120200557, LP120100552 |
| National Science Foundation Arctic Social Science Program | CHE- 0923473 |
| Wellcome Trust Biomedical Resources | 099156/Z/12/Z. |
| Australian National Health and Medical Research Council | 1042272 |
| Wellcome Trust | 099156 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- General Chemistry
- General Chemical Engineering
Huella
Profundice en los temas de investigación de 'Open source drug discovery: Highly potent antimalarial compounds derived from the tres cantos arylpyrroles'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver